This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1994 Jan 22;308(6923):273.

doi: 10.1136/bmj.308.6923.273b.

Safe blood? HTLV-1 infection is crippling

J A Copplestone, A G Prentice, M D Hamon, J Gawler, N Anderson

PMID: 8111279
PMCID: PMC2539332
DOI: 10.1136/bmj.308.6923.273b

Comment

Safe blood? HTLV-1 infection is crippling

J A Copplestone et al. BMJ. 1994.

. 1994 Jan 22;308(6923):273.

doi: 10.1136/bmj.308.6923.273b.

Authors

J A Copplestone, A G Prentice, M D Hamon, J Gawler, N Anderson

PMID: 8111279
PMCID: PMC2539332
DOI: 10.1136/bmj.308.6923.273b

No abstract available

PubMed Disclaimer

Comment on

Human T cell leukaemia/lymphoma virus and blood donation.
Dalgleish AG. Dalgleish AG. BMJ. 1993 Nov 13;307(6914):1224-5. doi: 10.1136/bmj.307.6914.1224. BMJ. 1993. PMID: 8281049 Free PMC article. No abstract available.
Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
Brennan M, Runganga J, Barbara JA, Contreras M, Tedder RS, Garson JA, Tuke PW, Mortimer PP, McAlpine L, Tosswill JH, et al. Brennan M, et al. BMJ. 1993 Nov 13;307(6914):1235-9. doi: 10.1136/bmj.307.6914.1235. BMJ. 1993. PMID: 8281054 Free PMC article.

Similar articles

Screening blood products for HTLV-I: what is the best approach?
Vesilind GW, Koepke JA, DesHarnais GR. Vesilind GW, et al. Transfus Sci. 1990;11(1):103-12. doi: 10.1016/0955-3886(90)90017-D. Transfus Sci. 1990. PMID: 10149525
[The significance of HTLV-1 and HIV-2 for transfusion medicine in Europe].
Gürtler L. Gürtler L. Beitr Infusionsther. 1989;24:27-32. Beitr Infusionsther. 1989. PMID: 2481545 Review. German.
[Cost-effective approach to the screening of HIV, HBV, HCV, HTLV in blood donors in France].
Sailly JC, Lebrun T, Coudeville L. Sailly JC, et al. Rev Epidemiol Sante Publique. 1997 Apr;45(2):131-41. Rev Epidemiol Sante Publique. 1997. PMID: 9221442 Review. French.
Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
Murphy EL. Murphy EL. Transfus Clin Biol. 2016 Feb;23(1):13-9. doi: 10.1016/j.tracli.2015.12.001. Epub 2016 Jan 5. Transfus Clin Biol. 2016. PMID: 26778839 Free PMC article. Review.
Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR, Kiely P, Keller AJ. Seed CR, et al. Intern Med J. 2005 Oct;35(10):592-8. doi: 10.1111/j.1445-5994.2005.00926.x. Intern Med J. 2005. PMID: 16207258

See all similar articles

Cited by

A SHOT in the arm for safer blood transfusion.
Williamson LM, Heptonstall J, Soldan K. Williamson LM, et al. BMJ. 1996 Nov 16;313(7067):1221-2. doi: 10.1136/bmj.313.7067.1221. BMJ. 1996. PMID: 8939097 Free PMC article. No abstract available.

References

1. BMJ. 1993 Nov 13;307(6914):1224-5 - PubMed
1. BMJ. 1993 Nov 13;307(6914):1235-9 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information